Successful treatment of human granulocytic ehrlichiosis in children using rifampin.

71Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne infectious disease caused by Anaplasma phagocytophilum. Clinical features include a flu-like illness that usually resolves within 1 week. More serious infection may occur that requires hospital admission or culminates in death. Doxycycline is the treatment of choice for HGE but may cause permanent staining of teeth in children younger than 8 years of age. We report successful treatment of HGE with rifampin in 2 children, 4 and 6 years old. A course of rifampin for 5 to 7 days should be considered in children younger than 8 years of age who experience non-life-threatening A phagocytophilum infection.

Cite

CITATION STYLE

APA

Krause, P. J., Corrow, C. L., & Bakken, J. S. (2003). Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics, 112(3 Pt 1). https://doi.org/10.1542/peds.112.3.e252

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free